Holen Sie sich die Stockscreener-App
3.74
1.20%
-0.02
Handel nachbörslich:
3.74
Rezolute Inc Aktie (RZLT) Neueste Nachrichten
Here's Why Rezolute (RZLT) Looks Ripe for Bottom Fishing - Nasdaq
Analysts Set Rezolute, Inc. (NASDAQ:RZLT) Price Target at $24.38 - Defense World
JMP Securities lifts Rezolute stock target to $9, maintains rating - MSN
Rezolute, Inc. (NASDAQ:RZLT) Receives Average Rating of "Buy" from Analysts - MarketBeat
A Guide To The Risks Of Investing In Rezolute Inc (RZLT) - Knox Daily
Insider Buying: Wladimir Hogenhuis Acquires Additional Shares of Rezolute Inc (RZLT) - GuruFocus.com
Rezolute director Wladimir Hogenhuis purchases $47,000 in common shares By Investing.com - Investing.com Nigeria
Rezolute director Wladimir Hogenhuis purchases $47,000 in common shares - Investing.com India
Hedge Fund and Insider Trading News: Scott Bessent, Warren Buffett, Stanley Druckenmiller, Tybourne Capital Management, Millennium Management, Rezolute Inc (RZLT), Rambus Inc (RMBS), and More - Insider Monkey
Insider Trading Highlights: Wednesday's Key Moves in US Stocks - Investing.com
Short Interest in Rezolute, Inc. (NASDAQ:RZLT) Rises By 17.4% - MarketBeat
Rezolute director Kim Young-Jin buys $5 million in shares By Investing.com - Investing.com Australia
Rezolute director Kim Young-Jin buys $5 million in shares - Investing.com
Rezolute's SWOT analysis: biotech stock advances on ersodetug trials - MSN
Rezolute (NASDAQ:RZLT) Receives "Buy" Rating from HC Wainwright - MarketBeat
JMP Securities Issues Positive Forecast for Rezolute (NASDAQ:RZLT) Stock Price - MarketBeat
Rezolute: Late-Stage Study Targeting Hyperinsulinism (NASDAQ:RZLT) - Seeking Alpha
Rezolute’s SWOT analysis: biotech stock advances on ersodetug trials By Investing.com - Investing.com Nigeria
What is Wedbush’s Estimate for Rezolute FY2029 Earnings? - Defense World
What is Wedbush's Estimate for Rezolute FY2029 Earnings? - MarketBeat
What is HC Wainwright’s Estimate for Rezolute Q1 Earnings? - Defense World
Rezolute (NASDAQ:RZLT) Releases Quarterly Earnings Results, Beats Estimates By $0.11 EPS - MarketBeat
Rezolute’s Strategic Advances in Rare Disease Therapies - MSN
Guggenheim Reiterates Buy Rating for Rezolute (NASDAQ:RZLT) - MarketBeat
JMP Securities lifts Rezolute stock target to $9, maintains rating By Investing.com - Investing.com Australia
Rezolute Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update - The Manila Times
Rezolute Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Rezolute Inc. (RZLT) reports earnings - Quartz
Rezolute, Inc. SEC 10-Q Report - TradingView
Rezolute's Hyperinsulinism Drug Hits Major FDA Milestone as Q2 Shows $105M War Chest - StockTitan
Analysts Set Rezolute, Inc. (NASDAQ:RZLT) PT at $24.13 - Defense World
H.C. Wainwright reiterates Buy on Rezolute shares, $14 target - MSN
Rezolute (NASDAQ:RZLT) Receives Buy Rating from Guggenheim - Defense World
Rezolute Insiders Placed Bullish Bets Worth US$557.5k - Yahoo Finance
Rezolute, Inc. (NASDAQ:RZLT) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Rezolute (NASDAQ:RZLT) Raised to Strong-Buy at Craig Hallum - MarketBeat
Rezolute (NASDAQ:RZLT) Given Buy Rating at HC Wainwright - MarketBeat
Rezolute’s (RZLT) Buy Rating Reiterated at HC Wainwright - Defense World
Rezolute Inc (RZLT) Shares Decline Despite Market Challenges - The News Heater
Analytical Overview: Rezolute Inc (RZLT)’s Ratios Tell a Financial Story - The Dwinnex
Rezolute (RZLT) to Announce Earnings on Tuesday - MarketBeat
5.68%
0.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):